There are some positive commercial developments for the company. The mega-insurer Cigna stated it will cover ThyraMIR, a microRNA gene expression classifier for thyroid nodules, that Interpace Diagnostics developed.
The health insurer has covered another IDXG's drug ThyGenX since 2017. 80% of ThyGenX orders are coupled with an order for ThyraMIR, and the two tests are billed independently.
www.finstead.com/bit...diction-july-25-2018
The health insurer has covered another IDXG's drug ThyGenX since 2017. 80% of ThyGenX orders are coupled with an order for ThyraMIR, and the two tests are billed independently.
www.finstead.com/bit...diction-july-25-2018